Health
Cancer immunotherapy may self-limit its efficacy in fighting tumors, study finds – News-Medical.net
Cancer immunotherapy involving drugs that inhibit CTLA-4 also activates an unwanted response that may self-limit its efficacy…
Cancer immunotherapy involving drugs that inhibit CTLA-4 also activates an unwanted response that may self-limit its efficacy in fighting tumors, according to a new study led by Francesco Marangoni, Ph.D., assistant professor of physiology & biophysics…
Continue Reading
-
General23 hours agoDeath of 86-year-old driver in Karoonda Highway crash prompts push for change
-
General20 hours agoTop chess player Magnus Carlsen forced into draw in historic game against over 134,000 people
-
Business19 hours agoIs Warren Buffett’s Berkshire Hathaway the smartest investment you can make today?
-
Noosa News24 hours agoPaint-filled extinguisher used in attack on Peter Dutton’s office